News

Fat accumulation in the liver, common in both non-drinkers (NAFLD, now MASLD) and those who consume alcohol (AFLD), may ...
Sagimet Biosciences (NASDAQ:SGMT) stock rises as Canaccord Genuity endorses the company's liver drug denifanstat as it launches coverage with a Buy. Read more here.
Altimmune's pemvidutide showed strong MASH resolution and good tolerability in IMPACT, but fibrosis data fell short. See why ...
A Virginia Commonwealth University (VCU) gastroenterologist and a global team of researchers have developed an artificial intelligence model that significantly improves doctors’ ability to predict ...
Alcohol-related liver disease has more than doubled in the U.S. over the last 20 years.
Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.
Metabolic dysfunction-associated steatotic liver disease is the leading driver of compensated advanced liver disease in the US.
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.
Background Steatotic liver disease-related hepatocellular carcinoma (SLD-HCC), a rising global challenge, is characterised by ...
Hepatitis and fatty liver disease, major causes of chronic liver injury, often present with subtle, easily overlooked ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...